CA-327

N/A

Report date: 2024/01/26 15:35:56
NMEFirst In Class

Base Information

Drug NameCA-327
Drug Alias NameAUPM-327CA-327
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 antagonistsHepatitis A virus cellular receptor 2 antagonists
TargetsHepatitis A virus cellular receptor 2Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Discovery Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuris Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A